Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2025 financial results on Tuesday, February 24, 2026....

RGEN : 139.60 (-2.42%)
3 Volatile Stocks Walking a Fine Line

3 Volatile Stocks Walking a Fine Line

GETY : 1.0650 (-7.39%)
RGEN : 139.60 (-2.42%)
JLL : 303.79 (-12.26%)
2 Cash-Producing Stocks to Target This Week and 1 We Ignore

2 Cash-Producing Stocks to Target This Week and 1 We Ignore

MRK : 118.79 (+1.40%)
RGEN : 139.60 (-2.42%)
URBN : 70.22 (-0.31%)
3 Reasons to Sell RGEN and 1 Stock to Buy Instead

3 Reasons to Sell RGEN and 1 Stock to Buy Instead

RGEN : 139.60 (-2.42%)
3 High-Flying Stocks That Fall Short

3 High-Flying Stocks That Fall Short

CGNX : 42.36 (-2.80%)
PEN : 339.08 (+0.03%)
RGEN : 139.60 (-2.42%)
Why Repligen (RGEN) Shares Are Sliding Today

Why Repligen (RGEN) Shares Are Sliding Today

RGEN : 139.60 (-2.42%)
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair

WALTHAM, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that the Board has elected...

RGEN : 139.60 (-2.42%)
1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges

1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges

RGEN : 139.60 (-2.42%)
PINS : 19.27 (-5.21%)
MANH : 144.98 (-3.11%)
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

WALTHAM, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate...

RGEN : 139.60 (-2.42%)
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new...

RGEN : 139.60 (-2.42%)

Barchart Exclusives

Should You Buy, Sell, or Hold HOOD Stock in February 2026?
A disappointing earnings Q4 report, crypto jitters, and the confirmation of a CFO transition has caused a selloff in Robinhood’s stock. Should you buy it here? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar